L. T. Cooper, G. J. Berry, and R. Shabetai, Idiopathic Giant-Cell Myocarditis ??? Natural History and Treatment, New England Journal of Medicine, vol.336, issue.26, pp.1860-1866, 1997.
DOI : 10.1056/NEJM199706263362603

K. Ekstrom, J. Lehtonen, R. Kandolin, A. Raisanen-sokolowski, K. Salmenkivi et al., Long-term outcome and its predictors in giant cell myocarditis, European Journal of Heart Failure, vol.165, issue.12, pp.1452-1460, 2016.
DOI : 10.1093/aje/kwk052

R. Kandolin, J. Lehtonen, K. Salmenkivi, A. Raisanen-sokolowski, J. Lommi et al., Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression, Circulation: Heart Failure, vol.6, issue.1, pp.15-22, 2013.
DOI : 10.1161/CIRCHEARTFAILURE.112.969261

L. T. Cooper, J. M. Hare, and H. D. Tazelaar, Usefulness of Immunosuppression for Giant Cell Myocarditis, The American Journal of Cardiology, vol.102, issue.11, pp.1535-1544, 2008.
DOI : 10.1016/j.amjcard.2008.07.041

R. A. Davies, J. P. Veinot, S. Smith, P. Struthers, R. Hendry et al., Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome, The Journal of Heart and Lung Transplantation, vol.21, issue.6, pp.674-683, 2002.
DOI : 10.1016/S1053-2498(02)00379-0

J. J. Maleszewski, V. M. Orellana, D. O. Hodge, U. Kuhl, H. P. Schultheiss et al., Long-Term Risk of Recurrence, Morbidity and Mortality in Giant Cell Myocarditis, The American Journal of Cardiology, vol.115, issue.12, pp.1733-1741, 2015.
DOI : 10.1016/j.amjcard.2015.03.023

R. Davidoff, I. Palacios, J. Southern, J. T. Fallon, J. Newell et al., Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes, Circulation, vol.83, issue.3, pp.953-61, 1991.
DOI : 10.1161/01.CIR.83.3.953

P. Ponikowski, A. A. Voors, and S. D. Anker, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European Journal of Heart Failure, vol.37, issue.8, pp.2129-200, 2016.
DOI : 10.1016/j.jpainsymman.2007.12.015

A. Combes, P. Leprince, and C. E. Luyt, Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock*, Critical Care Medicine, vol.36, issue.5, pp.1404-1415, 2008.
DOI : 10.1097/CCM.0b013e31816f7cf7

M. Mirabel, C. E. Luyt, and P. Leprince, Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support*, Critical Care Medicine, vol.39, issue.5, pp.1029-1064, 2011.
DOI : 10.1097/CCM.0b013e31820ead45

W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, APACHE II, Critical Care Medicine, vol.13, issue.10, pp.818-847, 1985.
DOI : 10.1097/00003246-198510000-00009

J. R. Le, S. Gall, F. Lemeshow, and . Saulnier, A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study, Jama, vol.270, pp.2957-63, 1993.

J. L. Vincent, R. Moreno, and J. Takala, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure, Intensive Care Medicine, vol.21, issue.7, pp.707-717, 1996.
DOI : 10.1007/BF01726543

G. Wernovsky, D. Wypij, and R. A. Jonas, Postoperative Course and Hemodynamic Profile After the Arterial Switch Operation in Neonates and Infants : A Comparison of Low-Flow Cardiopulmonary Bypass and Circulatory Arrest, Circulation, vol.92, issue.8, pp.2226-2261, 1995.
DOI : 10.1161/01.CIR.92.8.2226

L. W. Stevenson, F. D. Pagani, and J. B. Young, INTERMACS Profiles of Advanced Heart Failure: The Current Picture, The Journal of Heart and Lung Transplantation, vol.28, issue.6, pp.535-576, 2009.
DOI : 10.1016/j.healun.2009.02.015

C. A. Elamm, S. G. Al-kindi, C. M. Bianco, B. P. Dhakal, and G. H. Oliveira, Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry, Journal of Cardiac Failure, vol.23, issue.7, pp.566-575, 2017.
DOI : 10.1016/j.cardfail.2017.04.015

E. S. Brilakis, L. J. Olson, and G. J. Berry, Survival Outcomes of Patients with Giant Cell Myocarditis Bridged by Ventricular Assist Devices, ASAIO Journal, vol.46, issue.5, pp.46-569, 2000.
DOI : 10.1097/00002480-200009000-00011

N. A. Gilotra, N. Minkove, and M. K. Bennett, Lack of Relationship Between Serum Cardiac Troponin I Level and Giant Cell Myocarditis Diagnosis and Outcomes, Journal of Cardiac Failure, vol.22, issue.7, pp.583-588, 2016.
DOI : 10.1016/j.cardfail.2015.12.022

L. K. Murray, J. Gonzalez-costello, and S. N. Jonas, Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis, European Journal of Heart Failure, vol.4, issue.7 Suppl, pp.312-320, 2012.
DOI : 10.1161/CIRCHEARTFAILURE.110.958520

J. Seeburger, N. Doll, S. Doll, M. A. Borger, and F. W. Mohr, Mechanical assist and transplantation for treatment of giant cell myocarditis, Canadian Journal of Cardiology, vol.26, issue.2, pp.96-103, 2010.
DOI : 10.1016/S0828-282X(10)70011-8

E. Ammirati, F. Oliva, and O. Belli, Giant cell myocarditis successfully treated with antithymocyte globuline and extracorporeal membrane oxygenation for 21 days, Journal of Cardiovascular Medicine, vol.17, 2015.
DOI : 10.2459/JCM.0000000000000250

D. Steinhaus, E. Gelfand, P. A. Vanderlaan, and R. D. , Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support, The Journal of Heart and Lung Transplantation, vol.33, issue.7, pp.769-71, 2014.
DOI : 10.1016/j.healun.2014.02.018

H. J. Ankersmit, R. Ullrich, and B. Moser, Recovery from Giant Cell Myocarditis with ECMO Support and Utilisation of Polyclonal Antithymocyte Globulin: A Case Report, The Thoracic and Cardiovascular Surgeon, vol.54, issue.4, pp.278-80, 2006.
DOI : 10.1055/s-2006-923803

U. Grabmaier, C. Brenner, and H. Methe, An alternative immunosuppressive regimen to prolong transplant free survival in a patient with giant cell myocarditis, International Journal of Cardiology, vol.168, issue.1, pp.27-35, 2013.
DOI : 10.1016/j.ijcard.2013.05.078

L. J. Pinderski, G. C. Fonarow, and M. Hamilton, Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy, The Journal of Heart and Lung Transplantation, vol.21, issue.7, pp.818-839, 2002.
DOI : 10.1016/S1053-2498(01)00396-5

A. Suarez-barrientos, J. Wong, A. Bell, H. Lyster, G. Karagiannis et al., Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis, The American Journal of Cardiology, vol.116, issue.3, pp.447-51, 2015.
DOI : 10.1016/j.amjcard.2015.04.040

E. Ammirati, M. Cipriani, and M. Lilliu, Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis, Circulation, vol.136, issue.6, pp.529-574, 2017.
DOI : 10.1161/CIRCULATIONAHA.117.026386

K. Ekstrom, J. Lehtonen, R. Kandolin, A. Raisanen-sokolowski, K. Salmenkivi et al., Incidence, Risk Factors, and Outcome of Life-Threatening Ventricular Arrhythmias in Giant Cell Myocarditis, Circulation: Arrhythmia and Electrophysiology, vol.9, issue.12, 2016.
DOI : 10.1161/CIRCEP.116.004559

L. T. Cooper, K. L. Baughman, and A. M. Feldman, The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology, Circulation, vol.116, issue.19, pp.2216-2249, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.186093

R. Lorusso, P. Centofanti, and S. Gelsomino, Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis??in??Adult Patients: A 5-Year Multi-Institutional Experience, The Annals of Thoracic Surgery, vol.101, issue.3, pp.919-945, 2016.
DOI : 10.1016/j.athoracsur.2015.08.014

A. L. Caforio, S. Pankuweit, and E. Arbustini, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, European Heart Journal, vol.321, issue.16, pp.2636-2684, 2013.
DOI : 10.1056/NEJM198910193211601

B. Maisch, V. Ruppert, and S. Pankuweit, Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options, Current Heart Failure Reports, vol.103, issue.18, pp.166-77, 2014.
DOI : 10.1161/01.CIR.103.18.2254

R. C. Shields, H. D. Tazelaar, G. J. Berry, and L. T. Cooper, The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis, Journal of Cardiac Failure, vol.8, issue.2, pp.74-82, 2002.
DOI : 10.1054/jcaf.2002.32196

C. Chimenti and A. Frustaci, Contribution and Risks of Left Ventricular Endomyocardial Biopsy in Patients With Cardiomyopathies: A Retrospective Study Over a 28-Year Period, Circulation, vol.128, issue.14, pp.1531-1572, 2013.
DOI : 10.1161/CIRCULATIONAHA.13.001414

A. Kalra, R. Kneeland, M. A. Samara, and L. T. Cooper, The Changing Role for Endomyocardial Biopsy in the Diagnosis of Giant-Cell Myocarditis, Cardiology and Therapy, vol.6, issue.14, pp.53-62, 2014.
DOI : 10.1161/CIRCHEARTFAILURE.112.969261

A. Yilmaz, I. Kindermann, and M. Kindermann, Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance, Circulation, vol.122, issue.9, pp.900-909, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.924167

M. Noutsias and C. Tschope, Giant cell myocarditis: still a conundrum. The need for a worldwide registry, European Journal of Heart Failure, vol.373, issue.12, pp.1459-61, 2016.
DOI : 10.1056/NEJMoa1406761